Thanks, others will want see that for sure. I saw his credentials back in March, which is why I bought at .02/share
I should have bought the dips too. Today I did what all the others did the last 4 rallies, I sold and took profits.
When it looks undervalued again I will buy dips, and will continue to do my own value analysis as news continues to drop.
He obviously has lots of potential to make some huge deals, and drop news bombs like this one. Impressive rally today. One thing is for sure, they can drop massive legitimate news bombs and he make some great well informed drug deals.
"Paul M Michaels - Chief Executive Officer - Connectyx Technologies
For the past two decades, established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field Expertise in financing, risk management, global business development, mergers and acquisitions and cross-border pharmaceutical licensing. Completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and… "
Market Data 
Markets 
AI
